PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
This Quarter Return
-3.76%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$16.4B
AUM Growth
+$16.4B
(-8.1%)
Cap. Flow
-$276M
Cap. Flow
% of AUM
-1.68%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
327
New
21
Increased
103
Reduced
86
Closed
34
Top Buys
| 1 |
Alibaba
BABA
|
$283M |
| 2 |
Advanced Micro Devices
AMD
|
$127M |
| 3 |
CrowdStrike
CRWD
|
$123M |
| 4 |
Snowflake
SNOW
|
$101M |
| 5 |
Flex
FLEX
|
$92.3M |
Top Sells
| 1 |
Datadog
DDOG
|
$144M |
| 2 |
Microsoft
MSFT
|
$124M |
| 3 |
Reddit
RDDT
|
$123M |
| 4 |
Broadcom
AVGO
|
$114M |
| 5 |
Amphenol
APH
|
$113M |
Sector Composition
| 1 | Technology | 39.77% |
| 2 | Financials | 20.29% |
| 3 | Healthcare | 15.67% |
| 4 | Communication Services | 11.2% |
| 5 | Consumer Discretionary | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Intercontinental Exchange
ICE
$101B
| $45.6M | 0.28% | 264,295 +22,755 | +9% | +$3.93M |
|
102
Hagerty
HGTY
$1.14B
| $45.2M | 0.28% | 5,000,000 | – | – |
|
103
Globant
GLOB
$2.96B
| $44.7M | 0.27% | 379,738 +48,841 | +15% | +$5.75M |
|
104
Supernus Pharmaceuticals
SUPN
$2.53B
| $44.6M | 0.27% | 1,362,340 -325,590 | -19% | -$10.7M |
|
105
First American
FAF
$6.72B
| $44.3M | 0.27% | 675,000 | – | – |
|
106
MoonLake Immunotherapeutics
MLTX
$3.54B
| $43M | 0.26% | 1,100,000 | – | – |
|
107
RLI Corp
RLI
$6.22B
| $41.8M | 0.25% | 520,000 +260,000 | +100% | +$20.9M |
|
108
Grab
GRAB
$20.3B
| $41.7M | 0.25% | +9,196,353 | New | +$41.7M |
|
109
Vaxcyte
PCVX
$4B
| $40.9M | 0.25% | 1,082,473 +108,828 | +11% | +$4.11M |
|
110
Merit Medical Systems
MMSI
$5.36B
| $40.5M | 0.25% | 382,697 | – | – |
|
111
Doximity
DOCS
$12.7B
| $38.9M | 0.24% | 670,636 +287,941 | +75% | +$16.7M |
|
112
Fabrinet
FN
$11.8B
| $38.3M | 0.23% | 193,892 -15,402 | -7% | -$3.04M |
|
113
Neuropace
NPCE
$303M
| $36.5M | 0.22% | +2,972,003 | New | +$36.5M |
|
114
Soleno Therapeutics
SLNO
$3.6B
| $35.7M | 0.22% | +500,000 | New | +$35.7M |
|
115
Regeneron Pharmaceuticals
REGN
$61.5B
| $34.9M | 0.21% | 55,000 -1,249 | -2% | -$792K |
|
116
Apellis Pharmaceuticals
APLS
$3.48B
| $34.5M | 0.21% | 1,577,175 | – | – |
|
|
AVDL
117
Avadel Pharmaceuticals
AVDL
$1.43B
| $34.1M | 0.21% | 4,355,964 -58,236 | -1% | -$456K |
|
118
Fidelity National Information Services
FIS
$36.5B
| $34M | 0.21% | 455,582 +16,622 | +4% | +$1.24M |
|
119
McKesson
MCK
$85.4B
| $33.6M | 0.2% | 49,886 -8,399 | -14% | -$5.65M |
|
120
Toast
TOST
$26.3B
| $32.3M | 0.2% | 974,098 +119,372 | +14% | +$3.96M |
|
121
Integer Holdings
ITGR
$3.78B
| $32.2M | 0.2% | 272,436 | – | – |
|
122
Bank of America
BAC
$376B
| $31.7M | 0.19% | 759,124 +62,661 | +9% | +$2.61M |
|
123
Vertiv
VRT
$48.7B
| $31.3M | 0.19% | 433,376 +350,576 | +423% | +$25.3M |
|
124
Abbott
ABT
$231B
| $31.2M | 0.19% | +235,004 | New | +$31.2M |
|
125
Agios Pharmaceuticals
AGIO
$2.19B
| $29.4M | 0.18% | 1,002,036 +375,000 | +60% | +$11M |
|